Dexamethasone Sodium Phosphate Injection, Solution
Product Images NDC 55150-239

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dexamethasone Sodium Phosphate (NDC 55150-239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (4 mg per mL Container Label)

Package Label-principal Display Panel (4 mg per mL Container Label)
This is a description of a Dexamethasone and Sodium Phosphate Injection in a single-dose vial. The product is intended for veterinary or medicinal use only and requires a prescription. The dosage strength is 4mg per mL, and it is manufactured in Windsor, NJ. The text also mentions to see USP regarding Dexamethasone and displays a National Drug Code (NDC) of 55150-237-01.*
FDA Label Image

Package Label-principal Display Panel (4 mg per mL Container-Carton (25 Vials))

Package Label-principal Display Panel (4 mg per mL Container-Carton (25 Vials))
This is a description of a medication called Dexamethasone Sodium Phosphate Injection USP used for Intravenous, Intramuscular, Intra-Artcuar, Soft Tisie or Invalosonal Use. The medication comes in Sterie and Single-Dose Vials. Each mL of this medication contains 4mg of Dexamethasone Phosphate, Sodium Sulfe 1 mg, Benayl Alcohol 10mg, Water forlnjection, Sodiu Ciral or sotonicty, pH adjusted with Otic Acid and/or Sodium Hydrodde. This medication is to be stored at 20-25°C (66°10 77°F) and is sensitive to heat, meaning it cannot be autoclaved. Note that the valstoppers are not made with natural rubber.*
FDA Label Image

Package Label-principal Display Panel (20 mg per 5 mL (4 mg / mL) Container Label)

FDA Label Image

Package Label-principal Display Panel (20 mg per 5 mL (4 mg / mL) Container-Carton (25 Vials))

Package Label-principal Display Panel (20 mg per 5 mL (4 mg / mL) Container-Carton (25 Vials))
This is a description of a medication called Dexamethasone Sodium Phosphate Injection USP. Each 1ml ml of the injection contains 4.37 mg of Dexamethasone Sodium Phosphate USP (equivalent to 4 mg of Dexamethasone Phosphate). The injection also contains other ingredients, including Sodium Sulfite, Benzyl Alcohol, Water for Injection, and Sodium Gitrate. The medication is used for intravenous, intramuscular, intra-articular, or intralesional use. It is sensitive to heat and should not be autoclaved. The medication comes in 25x5mL, multiple-dose vials, and is Rx only. The vial stoppers are not made with natural rubber latex. No information is available about Soitanonny &5/ or Auoxy.*
FDA Label Image

Package Label-principal Display Panel (120 mg per 30 mL (4 mg / mL) Container Label)

Package Label-principal Display Panel (120 mg per 30 mL (4 mg / mL) Container Label)
DICS AUROMIE is a multiple-dose vial containing Dexamethasone Sodium Phosphate Injection USP, with 120mg per 30mL (4mg/mL) concentration. It can be used for LM, Intra-Articular, Soft Tissue or Intralesional purposes. Each mL contains Dexamethasone Sodium Phosphate USP 4.37mg, and Sodium Citrate is added for isotonicity. The directions for use are provided in the package insert. It is suggested to store it at 20° to 25°C but avoid autoclaving and heat, and also protect it from light. The product is distributed by AuroMedics Pharma LLC, and the code for the product is TSDBUGH/13/2010_ made in India.*
FDA Label Image

Package Label-principal Display Panel (120 mg per 30 mL (4 mg / mL) Container-Carton (25 Vials))

Package Label-principal Display Panel (120 mg per 30 mL (4 mg / mL) Container-Carton (25 Vials))
This text is a description of a medication called Dexamethasone Sodium Phosphate Injection USP. It is provided in a Multiple-Dose Vial package containing 25 x 30 mL of solution. Each mL contains 4.37 mg of Dexamethasone Sodium Phosphate USP (equivalent to 4 mg of Dexamethasone Phosphate), Sodium Sulfite 1 mg, Benzy! Alcohol 10 mg, Water for Injection q.s. Sodium Citrate is used for isotonicity, and pH is adjusted with Citric Acid and/or Sodium Hydroxide. This medication can be administered intravenously, intramuscularly, intra-articularly, or intralesionally. The package insert should be reviewed for directions for use. The medication should be stored at 20° to 25°C and protected from light. The vial stoppers do not contain natural rubber latex. The medication is distributed by AuroMedics Pharma LLC, and made in India.*
FDA Label Image

Dexamethasone Sodium Phosphate Chemical Structure (Dexamethasone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.